Corrigendum: Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in China

Authors :: Xiaoyan Han
Chunxiang Jin
Gaofeng Zheng
Donghua He
Yi Zhao
Yi Li
Wenjun Wu
Weiyan Zheng
Guoqing Wei
Enfan Zhang
He Huang
Jingsong He
Zhen Cai
Source :: Frontiers in Oncology, Vol 11 (2021)
Publication Year :: 2021
Publisher :: Frontiers Media S.A., 2021.

Subjects :: multiple myeloma
maintenance
proteasome inhibitors
immunomodulators
optimal maintenance duration
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282

Full Text Access

Tools